Tüberkülozda ülkemiz verilerine güncel bir bakış

Ahmet Aktaş; Yaşar Nakipoğlu; Dilek Şatana

doi:10.31832/smj.1078274

Tüberkülozda ülkemiz verilerine güncel bir bakış

Abstract

Tüberküloz, Mycobacterium tuberculosis kompleks tarafından oluşturulan granülomatöz enfeksiyondur. Tüberküloz basili, dünya genelinde çok fazla kişide görülür ancak enfeksiyon oluşturma potansiyeli düşüktür. Enfeksiyon en sık az gelişmiş ülkelerde görülmekle birlikte, gelişmiş ülkelerde kentleşmenin yükselmesi ile toplu yaşam alanlarının ve buralarda zaman geçiren birey sayısında artış nedeni ile vakalar artmıştır. Dünya Sağlık Örgütü’nün tüberkülozu bitirme politikası gereğince olgu sayıları yakından kontrol edilmektedir. Dünya genelinde erişkin erkeklerde daha fazla oranda görülmektedir. HIV pozitif bireylerin tüberküloza olan hassasiyetleri bilinirken 2019 yılı içinde ortaya çıkan yeni tip Coronavirus, tüberküloz kaynaklı ölüm vakalarında artışa neden olmuştur. Vaka sayılarındaki artış ilaç tedavisi alan birey sayısının artmasına ve hastaların medikal takiplerinde aksaklıklar olmasına neden olmaktadır. İlaç kullanımının bırakılması en sık ilaç direncine sebep olan etkindir. Tüberküloz geçmişte olduğu gibi günümüzde de küresel halk sağlığı problemlerinin ilk sıralarında yer almaktadır. Yapılan çalışmalar ve alınan önlemler ile birlikte vaka sayılarında azalma trendi devam etmektedir. Bu azalışın sürekliliği için çalışmalar titizlikle devam etmelidir.

Keywords

References

Bansal LK, Gupta S, Gupta AK, Chaudhary P. Thyroid tuberculosis. Indian J Tuberc. 2021 Apr;68(2):272-278. doi: 10.1016/j.ijtb.2020.09.006. Epub 2020 Sep 12. PMID: 33845964.
Baylan O. Çok ilaca dirençli tüberkülozdan sonra yaygın ilaca dirençli ve tüm ilaçlara dirençli tüberküloz formları: Eski hastalığın yeni yüzleri. Mikrobiyol Bul 2011; 45(1): 181-95
Bektöre B, Haznedaroğlu T, Baylan O, Ozyurt M, Ozkütük N, Satana D, Cavuşoğlu C, Seber E. Çok İlaca Dirençli Tüberküloz İzolatlarında Yaygın İlaç Direncinin Araştırılması [Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates]. Mikrobiyol Bul. 2013 Jan;47(1):59-70. Turkish. doi: 10.5578/mb.4229. PMID: 23390903
Beyrer C, Shisana O, Baral SD, Milsana K, Mayer KH, Pozniak A, Walker BD, Mboup S, Sohn AH, Serwadda D, Rees H, Dvoriak S, Warren M, Thiam S, El-Sadr WM, Hospital X, Ryan O, Thomson N, Bekker LG. The science of Durban, AIDS 2016. J Int AIDS Soc. 2017 Jun 30;20(1):21781. doi: 10.7448/IAS.20.1.21781. PMID: 28692209; PMCID: PMC5515038.
Boeree MJ, Diacon AH, Dawson R, Narunsky K, du Bois J, Venter A, Phillips PP, Gillespie SH, McHugh TD, Hoelscher M, Heinrich N, Rehal S, van Soolingen D, van Ingen J, Magis-Escurra C, Burger D, Plemper van Balen G, Aarnoutse RE; PanACEA Consortium. A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis. Am J Respir Crit Care Med. 2015 May 1;191(9):1058-65. doi: 10.1164/rccm.201407-1264OC. PMID: 25654354.
Boeree MJ, Heinrich N, Aarnoutse R, Diacon AH, Dawson R, Rehal S, et al. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. Lancet Infect Dis. 2017 Jan;17(1):39-49. doi: 10.1016/S1473-3099(16)30274-2. Epub 2016 Oct 26. PMID: 28100438; PMCID: PMC5159618.
Borisov SE, Dheda K, Enwerem M, Romero Leyet R, D'Ambrosio L, Centis R, Sotgiu G, et al Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J. 2017 May 21;49(5):1700387. doi: 10.1183/13993003.00387-2017. PMID: 28529205.
Chapman JS, Dyerly MD. Social and Other Factors In Intrafamilial Transmission Of Tuberculosis. Am Rev Respir Dis. 1964 Jul;90:48-60. Doi: 10.1164/Arrd.1964.90.1.48. Pmıd: 14178626.

Churchyard G, Kim P, Shah NS, Rustomjee R, Gandhi N, Mathema B, Dowdy D, Kasmar A, Cardenas V. What We Know About Tuberculosis Transmission: An Overview. J Infect Dis. 2017 Nov 3;216(suppl_6):S629-S635. doi: 10.1093/infdis/jix362. PMID: 29112747; PMCID: PMC5791742.
D'Ambrosio L, Centis R, Tiberi S, Tadolini M, Dalcolmo M, Rendon A, Esposito S, Migliori GB. Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review. J Thorac Dis. 2017 Jul;9(7):2093-2101. doi: 10.21037/jtd.2017.06.16. PMID: 28840010; PMCID: PMC5542985.
Dheda K, Barry CE 3rd, Maartens G. Tuberculosis. Lancet. 2016 Mar 19;387(10024):1211-26. doi: 10.1016/S0140-6736(15)00151-8. Epub 2015 Sep 13. Erratum in: Lancet. 2016 Mar 19;387(10024):1162. Erratum in: Lancet. 2016 Mar 19;387(10024):1162. Erratum in: Lancet. 2016 May 21;387(10033):2092. PMID: 26377143.
Dobbs TE, Kimmerling ME. Mycobacterium tuberculosis. In AIDS Therapy E-Book. 2008, Philadelphia, PA: Elsevier
European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2021 – 2019 data. Copenhagen: WHO Regional Office for Europe; 2021.Erişim: 10.01.2022
Fong, I.W., Emerging and difficult to treat nontuberculous mycobacteria infections. Current Trends and Concerns in Infectious Diseases. Emerging Infectious Diseases of the 21st Century. Springer, Cham, 2020, p.289–317
Forrellad MA, Klepp LI, Gioffré A, et al. Virulence factors of the Mycobacterium tuberculosis complex. Virulence. 2013;4(1):3-66. doi:10.4161/viru.22329
Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019 Apr 20;393(10181):1642-1656. doi: 10.1016/S0140-6736(19)30308-3. Epub 2019 Mar 20. PMID: 30904262.
Githinji LN, Gray DM, Zar HJ. Lung function in HIV-infected children and adolescents. Pneumonia (Nathan). 2018 Jun 25;10:6. doi: 10.1186/s41479-018-0050-9. PMID: 29984134; PMCID: PMC6016126.
Glaziou P. Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020, medRxiv 2020.04.28.20079582; doi: https://doi.org/10.1101/2020.04.28.20079582
Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO, Erişim: 10.01.2022
Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med. 2016 Oct 25;13(10):e1002152. doi: 10.1371/journal.pmed.1002152. PMID: 27780211; PMCID: PMC5079585.
Influenza Raporu. Türküye Halk Sağlığı Genel Müdürlüğü https://grip.gov.tr/depo/influenzaraporu/2022/Haftalik_InfluenzaGrip_Surveyans Raporu_2021_51._Hafta_431b4.pdf Erişim: 10.01.2022
Jaganath D, Lamichhane G, Shah M. Carbapenems against Mycobacterium tuberculosis: a review of the evidence. Int J Tuberc Lung Dis. 2016 Nov;20(11):1436-1447. doi: 10.5588/ijtld.16.0498. PMID: 27776583.
Jha SK, Rathish B. Genitourinary Tuberculosis. 2022 Jan 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 32491490.
Jo KW, Yoo JW, Hong Y, Lee JS, Lee SD, Kim WS, Kim DS, Shim TS. Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen. Respir Med. 2014 Apr;108(4):654-9. doi: 10.1016/j.rmed.2014.01.010. Epub 2014 Jan 27. PMID: 24518046.
Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011 Jul 2;378(9785):57-72. doi: 10.1016/S0140-6736(10)62173-3. Epub 2011 Mar 21. PMID: 21420161.
Low M. The tuberculosis treatment pipeline: a breakthrough year for the treatment of XDR-TB. July 2017. http://www.pipelinereport. org/2017/tbtx. Erişim 10.01.2022.
MacPherson P, Lebina L, Motsomi K, Bosch Z, Milovanovic M, Ratsela A, Lala S, Variava E, Golub JE, Webb EL, Martinson NA. Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: Analysis of baseline data from a cluster-randomised trial. PLoS One. 2020 Mar 17;15(3):e0230376. doi: 10.1371/journal.pone.0230376. PMID: 32182274; PMCID: PMC7077873.
Mbuagbaw L. A review of available evidence on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis: data analysis report. 2017. http://www.who.int/tuberculosis/publications/2017/Appendix_GDGReport_Bedaquiline.pdf. Erişim: 10.01.2022
Milstein M, Lecca L, Peloquin C, Mitchison D, Seung K, Pagano M, Coleman D, Osso E, Coit J, Vargas Vasquez DE, Sanchez Garavito E, Calderon R, Contreras C, Davies G, Mitnick CD. Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial. BMC Infect Dis. 2016 Aug 27;16(1):453. doi: 10.1186/s12879-016-1790-x. PMID: 27567500; PMCID: PMC5002098.
Nathavitharana RR, Friedland JS. A tale of two global emergencies: tuberculosis control efforts can learn from the Ebola outbreak. Eur Respir J. 2015 Aug;46(2):293-6. doi: 10.1183/13993003.00436-2015. PMID: 26232473.
Ndjeka N, Conradie F, Schnippel K, Hughes J, Bantubani N, Ferreira H, Maartens G, Mametja D, Meintjes G, Padanilam X, Variava E, Pym A, Pillay Y. Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. Int J Tuberc Lung Dis. 2015 Aug;19(8):979-85. doi: 10.5588/ijtld.14.0944. PMID: 26162365.
Neuhouser AJ, Sallam A. Ocular Tuberculosis. 2021 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 32644729.
Nigsch A, Glawischnig W, Bagó Z, Greber N. Mycobacterium caprae Infection of Red Deer in Western Austria-Optimized Use of Pathology Data to Infer Infection Dynamics. Front Vet Sci. 2019 Jan 21;5:350. doi: 10.3389/fvets.2018.00350. PMID: 30719435; PMCID: PMC6348259.
Pala K, Gerçek H, Taş TA, Çakir R, Özgüç S, Yildiz T. 30 Years Retrospective Review of Tuberculosis Cases in a Tuberculosis Dispensary in Bursa/Nilufer, Turkey (1985-2014): Changes of Epidemics. Mediterr J Hematol Infect Dis. 2016 Nov 1;8(1):e2016059. doi: 10.4084/MJHID.2016.059. PMID: 27872739; PMCID: PMC5111538.
Pfyffer GE. Mycobacterium: general characteristics, laboratory detection, and staining procedures. Manual of Clinical Microbiology, Eleventh Edition. American Society of Microbiology, 2015, p 536–569.
Reis-de-Carvalho C, Monteiro J, Calhaz-Jorge C. Genital tuberculosis role in female infertility in Portugal. Arch Gynecol Obstet. 2021 Sep;304(3):809-814. doi: 10.1007/s00404-020-05956-x. Epub 2021 Jan 10. PMID: 33426568
Riley RL, Mills CC, Nyka W, Weinstock N, Storey PB, Sultan LU, Riley MC, Wells WF. Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a tuberculosis ward. 1959. Am J Epidemiol. 1995 Jul 1;142(1):3-14. doi: 10.1093/oxfordjournals.aje.a117542. PMID: 7785671.
Riley RL, Mills CC, O'Grady F, Sultan LU, Wittstadt F, Shivpuri DN. Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients. Am Rev Respir Dis. 1962 Apr;85:511-25. doi: 10.1164/arrd.1962.85.4.511. PMID: 14492300.
Riley RL, O’Grady F. Airborne infection: transmission and control. 1961, New York, NY: Macmillan,
Saini D, Hopkins GW, Seay SA, Chen CJ, Perley CC, Click EM, Frothingham R. Ultra-low dose of Mycobacterium tuberculosis aerosol creates partial infection in mice. Tuberculosis (Edinb). 2012 Mar;92(2):160-5. doi: 10.1016/j.tube.2011.11.007. Epub 2011 Dec 21. PMID: 22197183; PMCID: PMC3288716.
Santos NCS, Scodro RBL, Leal DC, do Prado SM, Micheletti DF, Sampiron EG, Costacurta GF, de Almeida AL, da Silva LA, Ieque AL, Ghiraldi Lopes LD, de Pádua RA, Siqueira VL, Caleffi-Ferracioli KR, Cardoso RF. Determination of minimum bactericidal concentration, in single or combination drugs, against Mycobacterium tuberculosis. Future Microbiol. 2020 Jan;15:107-114. doi: 10.2217/fmb-2019-0050. Epub 2020 Feb 17. PMID: 32064924.
Satana D, Erkose-Genc G, Tamay Z, Uzun M, Guler N, Erturan Z. Prevalence and drug resistance of mycobacteria in Turkish cystic fibrosis patients. Ann Clin Microbiol Antimicrob. 2014 Aug 13;13:28. doi: 10.1186/1476-0711-13-28. PMID: 25123237; PMCID: PMC4236507.
Snow KJ, Cruz AT, Seddon JA, Ferrand RA, Chiang SS, Hughes JA, Kampmann B, Graham SM, Dodd PJ, Houben RM, Denholm JT, Sawyer SM, Kranzer K. Adolescent tuberculosis. Lancet Child Adolesc Health. 2020 Jan;4(1):68-79. doi: 10.1016/S2352-4642(19)30337-2. Epub 2019 Nov 18. Erratum in: Lancet Child Adolesc Health. 2019 Nov 27;: PMID: 31753806; PMCID: PMC7291359.
Şengül A, Ogan N, Aydemir Y. Extrapulmonary Tuberculosis: A Retrospective Review of 331 Cases at Kocaeli Tubersulosis Dispansary. Med J Kocaeli 2015; 4: 4-9.
Trends in Tuberculosis 2020, Centers for Disease Control and Prevention https://www.cdc.gov/tb/publications/factsheets/statistics/tbtrends.htm Erişim 10.01.2022
Türkiye’de Verem Savaşı 2020 Raporu, T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, 1205, Ankara, 2021
Velásquez GE, Brooks MB, Coit JM, Pertinez H, Vargas Vásquez D, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Peloquin CA, Osso E, Tierney DB, Seung KJ, Lecca L, Davies GR, Mitnick CD. Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2018 Sep 1;198(5):657-666. doi: 10.1164/rccm.201712-2524OC. PMID: 29954183; PMCID: PMC6118011.
Wells WF. On air-borne infection. Study II. Droplets and droplet nuclei. Am J Hyg. 1934:611–8
World Health Organization, The use of bedaquiline in the treatment of multidrug-resistant tuberculosis: interim policy guidance. 2013.https://apps.who.int/iris/bitstream/handle/10665/84879/9789241505482_eng.pdf?sequence=1(Erişim 10.01.2022
Young DB, Gideon HP, Wilkinson RJ. Eliminating latent tuberculosis. Trends Microbiol. 2009 May;17(5):183-8. doi: 10.1016/j.tim.2009.02.005. Epub 2009 Apr 16. PMID: 19375916.

Details

Primary Language

Turkish

Subjects

Health Care Administration

Journal Section

Review

Authors

Ahmet Aktaş ^*
0000-0003-3243-6338
Türkiye

Yaşar Nakipoğlu
0000-0001-7979-7291
Türkiye

Dilek Şatana
0000-0002-8827-1504
Türkiye

Publication Date

September 29, 2022

Submission Date

February 28, 2022

Acceptance Date

August 15, 2022

Published in Issue

Year 2022 Volume: 12 Number: 3

DOI

https://doi.org/10.31832/smj.1078274

IZ

https://izlik.org/JA69SL56MH

Cite

RIS / Bibtex

APA

Aktaş, A., Nakipoğlu, Y., & Şatana, D. (2022). Tüberkülozda ülkemiz verilerine güncel bir bakış. Sakarya Medical Journal, 12(3), 586-595. https://doi.org/10.31832/smj.1078274

AMA

1.Aktaş A, Nakipoğlu Y, Şatana D. Tüberkülozda ülkemiz verilerine güncel bir bakış. Sakarya Medical Journal. 2022;12(3):586-595. doi:10.31832/smj.1078274

Chicago

Aktaş, Ahmet, Yaşar Nakipoğlu, and Dilek Şatana. 2022. “Tüberkülozda ülkemiz Verilerine Güncel Bir Bakış”. Sakarya Medical Journal 12 (3): 586-95. https://doi.org/10.31832/smj.1078274.

EndNote

Aktaş A, Nakipoğlu Y, Şatana D (September 1, 2022) Tüberkülozda ülkemiz verilerine güncel bir bakış. Sakarya Medical Journal 12 3 586–595.

IEEE

[1]A. Aktaş, Y. Nakipoğlu, and D. Şatana, “Tüberkülozda ülkemiz verilerine güncel bir bakış”, Sakarya Medical Journal, vol. 12, no. 3, pp. 586–595, Sept. 2022, doi: 10.31832/smj.1078274.

ISNAD

Aktaş, Ahmet - Nakipoğlu, Yaşar - Şatana, Dilek. “Tüberkülozda ülkemiz Verilerine Güncel Bir Bakış”. Sakarya Medical Journal 12/3 (September 1, 2022): 586-595. https://doi.org/10.31832/smj.1078274.

JAMA

1.Aktaş A, Nakipoğlu Y, Şatana D. Tüberkülozda ülkemiz verilerine güncel bir bakış. Sakarya Medical Journal. 2022;12:586–595.

MLA

Aktaş, Ahmet, et al. “Tüberkülozda ülkemiz Verilerine Güncel Bir Bakış”. Sakarya Medical Journal, vol. 12, no. 3, Sept. 2022, pp. 586-95, doi:10.31832/smj.1078274.

Vancouver

1.Ahmet Aktaş, Yaşar Nakipoğlu, Dilek Şatana. Tüberkülozda ülkemiz verilerine güncel bir bakış. Sakarya Medical Journal. 2022 Sep. 1;12(3):586-95. doi:10.31832/smj.1078274

Cited By

Central nervous system tuberculoma in children: tertiary hospital experience in Turkey in the last quarter century

Child's Nervous System

https://doi.org/10.1007/s00381-025-06820-6